Efficacy of dietary supplements as an adjunctive therapy for polycystic ovary syndrome: an umbrella meta-analysis
Frontiers in Nutrition · 29.10.2025 · 12
DOI: 10.3389/fnut.2025.1705284 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Nutrition, online erschienen am 29.10.2025. Verfasst von Rutong Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Anatomy & Reproductive Medicine Application Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Polycystic ovary syndrome (PCOS) affects 5–15% of reproductive-aged women and involves significant metabolic dysregulation, for which nutritional interventions show therapeutic potential.
Methods
This umbrella meta-analysis synthesizes evidence from 46 randomized trials ( n = 30,133) to evaluate dietary supplements targeting core PCOS pathways.
Methods
This umbrella meta-analysis synthesizes evidence from 46 randomized trials ( n = 30,133) to evaluate dietary supplements targeting core PCOS pathways.
Results
Key nutraceuticals demonstrate clinically relevant benefits: myo-inositol significantly improves insulin sensitivity (HOMA-IR SMD = −0.81) and SHBG levels (SMD = 9.65) by enhancing glucose transporter activity; probiotics reduce systemic inflammation (CRP SMD = −0.82) via gut-microbiota modulation; omega-3 fatty acids ameliorate dyslipidemia (LDL-C SMD = −9.57; HDL-C SMD = 2.31) through anti-inflammatory mechanisms. Plant-derived compounds like curcumin lower fasting glucose (SMD = −3.43) via NF-ĸB pathway inhibition, while green tea catechins reduce adiposity. Significant heterogeneity arises from variations in supplement bioavailability, dosing protocols, and patient metabolic phenotypes. Nevertheless, consistent evidence confirms that targeted nutrient supplementation modulates insulin signaling, lipid metabolism, and hormonal balance in PCOS. Emerging research priorities include personalized nutrition protocols leveraging nutrigenomic interactions and antioxidant-rich formulations (e.g., vitamin E, selenium).
Discussion
This work establishes a mechanistic foundation for integrating evidence-based nutraceuticals—particularly myo-inositol, probiotics, and omega-3s—into PCOS management, offering clinically actionable strategies while highlighting needs for standardized dosing and bioavailability studies. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/view/CRD42024602681 .
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Anatomy & Reproductive Medicine Application Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
- Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital, Hengyang, Hunan, China.
Zitieren
APA
Wang, R., Huang, K., Wang, M., Zou, W., Huang, Y., Jiang, W., Feng, Y., Shen, H., & Lei, X. (2025). Efficacy of dietary supplements as an adjunctive therapy for polycystic ovary syndrome: an umbrella meta-analysis. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1705284
Vancouver
Wang R, Huang K, Wang M, Zou W, Huang Y, Jiang W, et al. Efficacy of dietary supplements as an adjunctive therapy for polycystic ovary syndrome: an umbrella meta-analysis. Frontiers in Nutrition. 2025;12. doi:10.3389/fnut.2025.1705284
BibTeX
@article{Wang2025,
author = {Wang, Rutong and Huang, Kongwei and Wang, Mengyao and Zou, Wenhui and Huang, Yujun and Jiang, Wei and Feng, Yingqi and Shen, Huilong and Lei, Xiaocan},
title = {Efficacy of dietary supplements as an adjunctive therapy for polycystic ovary syndrome: an umbrella meta-analysis},
journal = {Frontiers in Nutrition},
year = {2025},
volume = {12},
doi = {10.3389/fnut.2025.1705284}
}
EUVIMED